INS and COVID-19: The renal cell carcinoma, neurotrophin, and HTLV-1 pathways affect the symptom of COVID-19 in aspect of regulation of pro-inflammatory cytokines [34–36], and the TCA and insulin pathways affect through host metabolic inhibition [37, 38].